Background and Objective: Optical clearing agents (OCAs) have shown promise for increasing the penetration depth of biomedical lasers by temporarily decreasing optical scattering within the skin. However, their translation to the clinic has been constrained by lack of practical means for effectively perfusing OCA within target tissues in vivo. The objective of this study was to address this limitation through combination of a variety of techniques to enhance OCA perfusion, including heating of OCA, microneedling and/or application of pneumatic pressure over the skin surface being treated (vacuum and/or positive pressure). While some of these techniques have been explored by others independently, the current study represents the first to explore their use together. Study Design/Materials and Methods: Propylene glycol (PG) OCA, either at room-temperature or heated to 458C, was topically applied to hydrated, body temperature ex vivo porcine skin, in conjunction with various combinations of microneedling pre-treatment (0.2 mm length microneedles, performed prior to OCA application), vacuum pre-treatment (17-50 kPa, performed prior to OCA application), and positive pressure post-treatment (35-172 kPa, performed after OCA application). The effectiveness of OCA perfusion was characterized via measurements of transmittance, reduced scattering coefficient, and penetration depth at a number of medicallyrelevant laser wavelengths across the visible spectrum. Results: Topical application of room-temperature (RT) PG led to an increase in transmittance across the visible spectrum of up to 21% relative to untreated skin. However, only modest increases were observed with addition of various combinations of microneedling pre-treatment, vacuum pre-treatment, and positive pressure post-treatment. Conversely, when heated PG was used in conjunction with these techniques, we observed significant increases in transmittance. Using an optimal PG perfusion enhancement protocol consisting of 458C heated PG þ microneedle pre-treatment þ 35 kPa vacuum pre-treatment þ 103 kPa positive pressure post-treatment, we observed up to 68% increase in transmittance relative to untreated skin, and up to 46% increase relative to topical RT PG application alone. Using the optimal PG perfusion enhancement protocol, we also observed up to 30% decrease in reduced scattering coefficient relative to untreated skin, and up to 20% decrease relative to topical RT PG alone. Finally, using the optimal protocol, we observed up to 25% increase in penetration depth relative to untreated skin, and up to 23% increase relative to topical RT PG alone. Conclusions: The combination of heated PG, microneedling pre-treatment, vacuum pre-treatment, and positive pressure-post treatment were observed to significantly enhance the perfusion of topically applied PG. Although further studies are required to evaluate the efficacy of combined perfusion enhancement techniques in vivo, the current results suggest promise for facilitating the translation of OCAs to the clinic.
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INTRODUCTION
Optical clearing agents (OCAs) are nonreactive hyperosmotic agents that are used to increase tissue transparency in a transient and reversible manner. Although the exact mechanisms are still not well understood, prevailing opinion suggests that clearing is achieved through reduced optical scattering arising from matching of OCA and tissue refractive indices (due to OCA ingress and water egress under osmotic pressure), and/or dehydration and ordering of tissue fibrils in the dermis [1] [2] [3] [4] . By providing means for transiently clearing skin, OCAs have shown promise for enhancing the performance of a variety of diagnostic techniques, such as optical coherence tomography [3, 5] , second harmonic generation microscopy [4, 6] , confocal microscopy [4, 6] and two-photon excited fluorescence microscopy [7] [8] [9] [10] , as well as many other medical applications [2, 5, [11] [12] [13] [14] [15] [16] [17] [18] . Optical clearing also represents a critical element of a new concept we have recently introduced, Windows to the Brain. In this concept, OCAs would allow transient clearing of the scalp overlying a transparent cranial implant, thus providing a minimallyinvasive means for optically accessing the brain, ondemand, over large areas, and on a chronically-recurring basis, without need for repeated craniectomies [19] .
However, despite this promise, the continuing lack of sufficiently effective and/or practical OCA perfusion techniques in vivo represents a limitation with regard to clinical translation. The high viscosity of OCAs results in poor penetration through the stratum corneum when applied topically, as well as slow perfusion within the epidermis. In ex vivo studies, rapid and effective clearing has only been achieved through complete immersion of excised tissue samples in OCA, which is not feasible for use in vivo [7] [8] [9] [10] . Single dose subdermal injection has been shown to produce fast clearing in vivo; however, this has been accompanied by necrosis and scarring, thus limiting the utility of this technique [20] . Sonophoresis and application of 1500 mm microneedles have shown potential for increasing clearing relative to topical application of OCA alone; however, visible damage to the stratum corneum was observed [21] . Finally, removal of the stratum corneum via sandpaper abrasion has been shown to enhance the transdermal delivery of OCA [22] ; however, inflammation was also observed.
Herein, we report the first systematic and quantitative study of OCA perfusion enhancement using various combinations of OCA heating, microneedling pre-treatment (i.e., prior to OCA application), vacuum pre-treatment (i.e., prior to OCA application), and/or positive pressure posttreatment (i.e., after OCA application). The motivation for OCA heating was based on recent studies demonstrating enhanced clearing performance with heating of glycerol up to 40-458C [23] . Moritz and Henriques [24] have previously studied time-surface thresholds for thermal injury of human skin and demonstrated that 2 hours of exposure to 458C at the surface of human skin has caused hyperemia without loss of epidermis. For this study, the exposure time of 458C OCA to skin was limited to 30 minutes. As such, epidermal loss is not expected, although hyperemia could still occur in vivo. The rationale for microneedling was based on the presumption that this would produce shallow pores that enable circumvention of the stratum corneum in a minimally invasive manner. The rationale for vacuum pre-treatment was based on the presumption that the resulting tissue stretching could enlarge pores produced by prior microneedling and therefore increase the OCA perfusion [25, 26] . Finally, the rationale for positive pressure post-treatment was based on the presumption that this could increase OCA flux through pores produced by prior microneedling.
MATERIALS AND METHODS

Skin Preparation
Ex vivo abdominal porcine skin with intact stratum corneum was used for all studies, due to its anatomical similarity to human skin [27] . Fresh skin was obtained from a local research facility (University of California Irvine, Department of Surgery). Upon receipt, the tissue was sealed to prevent dehydration and stored at 48C. All tissues were used within 2 weeks of receipt. Prior to each experiment, the skin samples were thawed and the subcutaneous fat layer was removed to yield samples of 1.5 mm AE 0.1 mm thickness, which included stratum corneum (26.4 AE 0.4 mm thickness [28] ), epidermis (65.8 AE 1.8 mm thickness [28] ), and dermis (balance of sample thickness). The prepared samples were then re-hydrated by immersion in room temperature (RT) saline for 30 minutes. For all experiments, RT was maintained at 188C and relative humidity at 30%.
OCA Perfusion
While a number of hyperosmotic agents have shown potential for use as OCAs, Propylene glycol (PG) (SigmaAldrich) was selected for the current studies, due to its superior permeability [29, 30] . In all experiments, 100 ml of PG was applied topically over an area of approximately 100 mm 2 , and total PG exposure time was maintained at 30 minutes. Thirty minutes was chosen on the basis of decreasing clearing rate as well as maintaining the experiment parameters within the context of eventual clinical practicality. For studies involving RT OCA, PG was dispensed from a container held under ambient conditions (188C). For studies involving heated OCA, PG was warmed to 458C using a hot plate prior to topical application. This temperature was selected to minimize PG viscosity (16.4 mPa Á s at 448C vs. 46.4 mPa Á s at 248C [31] ) without surpassing the threshold for thermal damage to the skin.
For studies involving microneedling pre-treatment (i.e., prior to OCA application), a commercial microneedle roller was manually applied to the skin samples in 08, 458, and 908 rolling directions over the same area, with thirty roller passes applied in each direction (CR2 MTS roller, Clinical Resolution Laboratory, Brea, CA; ISO 13485:2003 approved, microneedle length ¼ 0.2 mm, diameter ¼ 0.07 mm, and pitch ¼ 2.5 mm). The pore density produced by microneedling (Fig. 1a) were measured via topical dye application (trypan blue), followed by removal of excess dye, and finally, imaging with a Dermatoscope (3.5V ProPhysician Dermatolight-LED Dermatoscope) coupled with a digital camera (Kodak MAX Z990). Untreated (i.e., non-microneedled) tissue specimens were processed in a similar manner to serve as control (Fig. 1b) . The depth and diameter of pores produced by microneedling (Fig. 1c) was measured by topical application of Rhodamine R, followed by histological sectioning and imaging an average of twenty 40 mm thick slices per sample with a fluorescence microscope (Leica MZIII Pursuit). In each tissue section, an average of six pores was measured in randomized locations across the section, and measurements were only taken for pores with clearly defined boundaries (i.e., sharp demarcation between Rhodamine R (red) and the adjacent background (black)). Since many pores tapered with depth into the skin, the reported pore diameters are those measured at the skin surface. Collectively, these measurements indicated average pore density of 240 AE 10 pores/ cm 2 , average pore diameter of 0.22 AE 0.08 mm on the surface of skin, and average pore depth of 0.20 AE 0.04 mm for microneedled skin. Histological imaging of non-microneedled skin samples was also performed to characterize the native topographical variation of the skin (Fig. 1d) .
For studies involving pneumatic pressure, a custom apparatus ( Fig. 2a) was fabricated from transparent acrylic to allow application of pressure (negative or positive) to the epidermal surface of the skin samples. During these studies, sample hydration was maintained from the dermal surface via contact with an underlying body-temperature, saline-saturated, rigid foam block (Oasis Wet Floral Foam, Smithers-Oasis North America, Kent, OH). For studies involving vacuum pre-treatment (i.e., prior to OCA application), vacuum ranging from 17 kPa to 50 kPa was applied for 1 minute using a hand pump (9963K21, McMaster-Carr, Los Angeles, CA). For studies involving positive pressure post-treatment (i.e., after OCA application), pressure ranging from 35 to 172 kPa was applied for 4 minutes using house compressed air with a regulator (Harris Gas Regulator, Harris Products Group, Gainesville, GA).
Optical Clearing Characterization
After application of prescribed perfusion enhancement protocols, residual PG was removed from the skin surface by gentle wiping with an absorbent cloth, and the samples were immediately transferred to an optical measurement system. Transmittance and reflectance spectra across wavelengths ranging from 450 to 850 nm were measured using a fiber optic spectrometer (SD2000, Ocean Optics, Dunedin, FL). A fiber optic bundle with a 150 W quartz halogen illuminator was used as the light source for transmission measurements (Model 180, Fiber-Lite, Dolan Jenner, Boxborough, MA). Reflection was measured with a Spectralon coated integrating sphere with a built-in tungsten-halogen light source for 400-800 nm wavelengths (ISP-REF Integrating Sphere, Ocean Optics). The system was calibrated using a diffuse reflectance standard (WS-1, Ocean Optics). Measurements were made every 5 minutes for 30 minutes total, and all experiments were repeated in triplicate (Fig. 2b) .
Wavelength Selection
Specific attention was focused on optical response at the following wavelengths due to their relevance for various laser-based medical imaging and therapeutic modalities: (1) 532 nm for laser-induced photoacoustic brain imaging [32] ; (2) 630 nm for photosensitizer activation in photodynamic therapy of brain tumors [33] ; (3) 650 nm for near-infrared spectroscopy and topographical imaging of brain [34] ; (4) 670 nm for emerging photochemical internalization (PCI)-enhanced nonviral gene-directed enzyme prodrug cancer therapy [35] ; and (5) 810 nm for brain interstitial laser photocoagulation therapies [36] .
Data Analysis
Normalized transmittance, NT, was calculated using,
where T t was the transmittance of the skin sample measured at time t after completion of a prescribed OCA treatment protocol, and T 0 was the transmittance measured before application of the prescribed OCA treatment protocol (i.e., untreated skin baseline transmittance). The reduced scattering coefficient, m 0 s , which combines the transmittance, reflectance, and thickness of the sample, was calculated using Prahl's inverse addingdoubling algorithm.
In these calculations, the anisotropy factor was assumed to be 0.9 for skin in the visible and NIR spectral range, and m s represented the scattering coefficient [37] . Finally, the photon penetration depth, d, was estimated using the following expression [38] :
where m a represented the absorption coefficient at the measured wavelength, which was also calculated using the Prahl's inverse adding-doubling algorithm.
Statistical Analysis
All data was statistically analyzed using two-way repeated-measures ANOVA and Bonferroni post-tests. Statistics were calculated using a commercially-available software package (Prism 5.0, GraphPad, San Diego, CA). Fig. 2 . a: Schematic of apparatus used for pneumatic pressure OCA perfusion enhancement studies in ex vivo porcine skin. Tissue samples were placed within the apparatus such that their dermal surface was in contact with the underlying body-temperature, saline-saturated foam block, while the epidermal surface was exposed to vacuum and/or positive pressure. b: Block diagram illustrating the sequence of operations for application of the various PG perfusion enhancement techniques. Briefly, the hydrated porcine skin was treated with microneedles and was kept hydrated from the dermis side using a body temperature, saline-saturated foam block for 10 minutes before the start of each experiment. For studies involving vacuum pre-treatment, vacuum was applied for 1 minute. For studies involving positive pressure post-treatment, pressure was applied for 4 minutes after the PG application. The tissue was rested for 1 minute, and PG was removed before the measurement of optical properties (transmission/reflection). The steps including the PG and positive pressure post-treatment application, rest and removal of PG, and the measurement of optical properties were repeated for 30 minutes (6 times).
Changes were considered statistically significant when the P-value was less than 0.05.
Qualitative Demonstration of Optical Clearing Efficacy
To provide a qualitative demonstration of the efficacy of optical clearing in skin treated with the optimal PG perfusion enhancement protocol, we utilized a thermocavitation technique we reported previously [39, 40] . Briefly, treated ex vivo porcine skin was placed on the outer face of a quartz cuvette containing saturated aqueous copper nitrate solution (CuNO 4 ). The skin was then irradiated with an 810 nm CW laser operating at 12 W. Laser transmission through the cleared skin caused thermocavitation-induced bubble formation in the CuNO 4 solution, which was captured using a high speed video camera recording at 10 5 frames per second (Phantom V7, Version 9.1). Control experiments consisting of untreated skin subjected to identical conditions were also performed. Figure 3 shows the variation of NT with time after topical application on ex vivo skin samples with RT PG. The change in NT is significantly different after 20 minutes for some wavelengths and after 30 minutes for all wavelengths (P < 0.05). The statistical analysis indicates the effect of time was extremely significant (P < 0.001) and the effect of wavelength was very significant (P < 0.01), with more pronounced improvement at shorter wavelengths. Maximum NT was observed at 30 minutes for most wavelengths, with up to 21% improvement relative to untreated skin (P < 0.05). Based on this preliminary study, measurement time of 30 minutes after treatment was selected for subsequent perfusion enhancement studies. The relatively modest increase in NT confirms the strong barrier function of the stratum corneum, which precludes significant clearing with topical RT PG alone. Figure 4 shows the variation of NT with time after treatment of microneedled skin with RT PG. The change in NT is significantly different after 30 minutes for all wavelengths (P < 0.05), thus supporting the appropriateness of this measurement time point for subsequent microneedling-based perfusion enhancement studies. Interestingly, only minimal enhancement of transmittance was observed relative to RT PG alone (i.e., Fig. 3) . Moreover, the effect of microneedling seemed to be more pronounced for longer wavelengths, although the underlying cause is unclear. While other studies using the same region of skin (abdominal) as in this study have shown up to two-fold increase in NT with microneedling [41] , this may be due to the longer needle length used in those studies (i.e., 500 mm microneedle roller vs. 200 mm for the current study). While both needle lengths are sufficient to circumvent the stratum corneum and access the epidermis, longer needles may produce deeper pores, which could facilitate OCA perfusion. However, longer needles may also increase pain sensation, thus producing a potential tradeoff between clearing efficacy and invasiveness when used in vivo. Figure 5 shows the variation of NT with vacuum pretreatment pressures for microneedled skin treated with RT PG, all 30 minutes after treatment. The data showed no statistically significant variation in NT with vacuum pretreatment pressure (P > 0.05). This suggests that minimal pore enlargement was produced within this pressure range, or alternatively, that any pore enlargement that was achieved was insufficient in and of itself to enhance perfusion of RT PG. As such, 35 kPa vacuum pre-treatment pressure was arbitrarily selected for subsequent perfusion enhancement studies. Fig. 3 . Variation of NT at various medically relevant laser wavelengths with time after treatment of hydrated, ex vivo porcine skin with room temperature propylene glycol (PG). All data are normalized by transmittance for each skin sample before PG application (i.e., untreated skin). N ¼ 3 for each condition and error bars represent 1 standard deviation, two-way ANOVA repeated measures, Bonferroni post-test Ã P < 0.05, ÃÃ P < 0.01, ÃÃÃ P < 0.001 relative to 0 minute.
RESULTS AND DISCUSSION
Variation of Transmittance With Time
Variation of Transmittance With Vacuum Pre-Treatment Pressure
Variation of Transmittance With Positive Pressure
Post-Treatment Figure 6 shows the variation of NT with positive posttreatment pressure for microneedled skin treated with RT PG, all 30 minutes after treatment. Maximum NT was observed at 103 kPa for most wavelengths, with up to 41% and 37% improvement relative to untreated skin and RT PG alone, respectively (P < 0.01). The decrease of NT beyond 103 kPa is likely due to observed PG splashing onto the sidewalls of the pneumatic apparatus at higher pressure, which may have reduced the amount available for perfusion. Based on this preliminary study, positive post-treatment pressure of 103 kPa was selected for subsequent perfusion enhancement studies.
According to federal Occupational Safety and Health Administration (OSHA), the air pressure threshold that can cause damage if directed at open wounds or body openings is 207 KPa (30 psi) and the pressure tolerances over muscles and bones in human subjects have been reported in the range of 0.5-1.1 MPa [42] . Since the pressures applied in the current study are below these thresholds, pain and damage are not expected in vivo, although further studies in vivo will be required for confirmation. In mechanical tissue optical clearing technique where compression is the only factor in enhancement of light transmission through biological tissue, pressure applied was reported to be 0.13 MPa [26] . However, it is important to note that optical measurements were performed while the skin was pressurized [27] , whereas there was no applied pressure during measurement in the current study. While we presume that positive pressure facilitated tissue clearing by enhancing PG permeation, it All data are normalized by transmittance for each skin sample before pre-treatment with microneedles (i.e., untreated skin). N ¼ 3 for each condition and error bars represent 1 standard deviation. Two-way ANOVA repeated measures, Bonferroni post-test Ã P < 0.05, ÃÃ P < 0.01, ÃÃÃ P < 0.001 relative to 0 minute. Fig. 5 . Variation of transmittance with vacuum pre-treatment pressures for microneedled skin treated with room temperature PG. Measurements were made 30 minutes after treatment, and all data are normalized by transmittance for each skin sample before pre-treatment with vacuum and microneedles (i.e., untreated skin). N ¼ 3 for each condition and error bars represent 1 standard deviation. Two-way ANOVA repeated measures, Bonferroni post-test Ã P < 0.05, ÃÃ P < 0.01, ÃÃÃ P < 0.001 relative to 17 kPa. The NT results with different vacuum pre-treatment pressures for RT PG are not significantly different (P > 0.05).
is also conceivable that positive pressure enhanced PG solubility in collagen by increasing the PG interactions necessary for tissue clearing [40] .
PG Perfusion Enhancement With Combination of
Heating, Microneedling, and/or Pneumatic Pressure Figure 7 summarizes the variation of NT due to each of the perfusion enhancement techniques individually, as well as in various combinations, all 30 minutes after treatment. Up to 21% increase in NT was observed across most wavelengths after application of RT PG, and there was only modest additional increase with use of 458C heated PG (458C). This suggests that reduced viscosity was insufficient in and of itself for enhancing PG diffusion through the stratum corneum (P > 0.05), as would be expected. The results also demonstrated that use of microneedling pre-treatment (MN), 35 kPa vacuum pre-treatment (VP), and/or 103 kPa positive pressure . Measurements were made 30 minutes after treatment, and all data are normalized by transmittance for each skin sample before PG application and/or any perfusion enhancement pre-treatment techniques (i.e., untreated skin). Maximum transmittance was observed with the optimal PG perfusion enhancement protocol shown in the right-most bar at each wavelength, which consisted of heated PG in combination with microneedle and vacuum pre-treatment, followed by positive pressure post-treatment. N ¼ 3 for each condition and error bars represent 1 standard deviation. Two-way ANOVA repeated measures, Bonferroni post-test Ã P < 0.05, ÃÃ P < 0.01, ÃÃÃ P < 0.001 relative to RT PG.
post-treatment (PP), either separately or combined, lead to only modest enhancement of perfusion of RT PG at most wavelengths (P > 0.05). However, the data show that significant increases in NT were achieved when these techniques were used in conjunction with heated PG. This suggests that reduced viscosity facilitated the effectiveness of the microneedling and pneumatic pressure perfusion enhancement techniques. Finally, for all wavelengths, maximum NT was achieved using an optimal PG perfusion enhancement protocol consisting of topical application of 458C heated PG in conjunction with microneedle and 35 kPa vacuum pre-treatment, followed by 103 kPa positive pressure post-treatment (P < 0.001). Improvements in NT up to 68% relative to untreated skin, and up to 46% relative to topical application of RT PG, were observed. with each perfusion enhancement technique individually. However, when used together, in conjunction with heating, up to 30% decrease in m 0 s was observed relative to untreated skin, and up to 20% decrease was observed relative to topical RT PG (at least P < 0.05 for all wavelengths). Similarly, up to 25% increase in d was observed relative to untreated skin, and up to 23% increase was observed relative to topical RT PG (at least P < 0.05 for all wavelengths).
Collectively, Figures 7-9 demonstrate that significant improvement in clearing can be achieved using the optimal PG perfusion enhancement protocol. It is interesting to note that while the magnitude of clearing varies with laser wavelength, the correlation between wavelength and perfusion condition was not considered significant (P ¼ 0.8). Nevertheless, the optimal perfusion condition (458C, MN, VP, PP) has a definite enhancement trend across all wavelengths, albeit not in the same proportion. Figure 10a shows a schematic illustration of the experimental set up used for demonstration of optical clearing efficacy via thermocavitation. Figure 10b shows a sequence of stills captured from high-speed video recording of thermocavitation-induced bubble formation in CuNO 4 solution produced during laser fluence through hydrated, ex vivo porcine skin treated with the optimal PG perfusion enhancement protocol. Bubble formation was observed soon after laser turn-on and ceased soon after the laser was turned off. In contrast, no bubble formation was observed when untreated skin was used, and significant thermal damage was observed (data not shown). This demonstrates that well-controlled perfusion of PG within skin can increase the photon density delivered to a specific subsurface target while minimizing or confining the thermal damage. Determining the effect of less efficient PG perfusion enhancement protocol is beyond the scope of the current study, since the thermocavitation experiments were simply intended to serve as a proof-of-concept level demonstration of the enhanced clearing, independent of a particular application.
Qualitative Demonstration of Optical Clearing Efficacy
The current study has provided preliminary evidence supporting the potential afforded by combined microneedling, OCA heating, and pneumatic pressure for enhancing optical clearing performance. However, it is important to emphasize that these studies fail to reproduce the full complexity of the in vivo environment, and as such, further study is required to determine whether these techniques will yield similar improvements in clinical settings. Of particular importance in this regard, will be the effect of active perfusion by the vasculature in vivo, which may facilitate OCA transport away from the delivery site, and thus, reduce clearing efficacy. Moreover, while no visible skin damage was observed and most of the techniques used in this study have been demonstrated by others to be minimally invasive on an individual basis, it is unclear whether their use together will be similarly innocuous. Also, future studies need to be performed to examine the effect of various temperature between RT and 458C on the skin and the perfusion of PG. Lower PG is expected to reduce the clearing efficacy, due to increased viscosity of PG. Finally, it is unclear whether the magnitude and depth of clearing that could be achieved in vivo using such techniques will be sufficient for all applications. For example, it is conceivable that throughthickness clearing of thin tissues could be achieved using the current techniques (e.g., clearing of scalp for the aforementioned Windows to the Brain concept). However, for deeper clearing in thicker tissues, it is likely that longer microneedles would be required, which could increase pain and invasiveness.
CONCLUSIONS
In this study, we demonstrated, for the first time, the quantitative comparison of a variety of techniques to enhance optical clearing, including microneedling, OCA heating, and pneumatic pressure application. Application of the optimal combination of these techniques on ex vivo porcine tissue resulted in 68% increase in NT relative to untreated skin, and up to 46% increase relative to topical RT PG application alone. Enhancements in m 0 s and d were also observed. Collectively, this suggests potential for enhancing optical clearing performance in vivo, and thus, potential for facilitating the use of medical lasers in numerous clinical applications.
